<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: Gilboa Udi -->
          <cik>0001599094</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Ordinary Shares</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0002029039</issuerCik>
        <issuerName>Nasus Pharma Ltd.</issuerName>
        <issuerCusip>M7071P109</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>Yigal Alon 65,</com:street1>
          <com:city>Tel Aviv</com:city>
          <com:stateOrCountry>L3</com:stateOrCountry>
          <com:zipCode>6744317</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Udi Gilboa</reportingPersonName>
      <citizenshipOrOrganization>L3</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>1901311.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>1901311.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>1901311.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>21.1</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>(1) Based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Nasus Pharma Ltd.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>Yigal Alon 65, Tel Aviv, 6744317, Israel.</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This Statement is filed on behalf of Udi Gilboa.</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>The address of the Reporting Persons is:

c/o Nasus Pharma Ltd.
Yigal Alon 65,
Tel Aviv, 6744317, Israel</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Udi Gilboa is a citizen of the State of Israel.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>1,901,311 ordinary shares</amountBeneficiallyOwned>
        <classPercent>21.1%.

Based on 9,014,105 ordinary shares that the issuer has advised the Reporting Person were issued and outstanding as of September 30, 2025.</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>1,901,311</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>1,901,311</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Udi Gilboa</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Udi Gilboa</signature>
        <title>Udi Gilboa</title>
        <date>11/10/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
